Drugs / Cellgram-CLI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02477540 | Dec 2019 → Jun 2020 | limb ischemia | Pharmicell Co., Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellgram-CLI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02477540 ↗ |
| Route | Intramuscular | “Injection Method: Intramuscular” NCT02477540 ↗ |